mediantechnologies.com rapport :   Visitez le site

Données techniques du mediantechnologies.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte mediantechnologies.com.Actuellement, hébergé dans France et son fournisseur de services est TAS France .

the related websites

domaine	Titre
mediantechnologies.com	MEDIAN Technologies - Home
nds.com.pk	home - nds technologies pvt. ltd.
amstechnologies.com	home - ams technologies ag
foliomedian.com	plateforme sms, un outil puissant et avan gardiste de folio median
inglobetechnologies.com	inglobe technologies | home
alpestechnologies.fr	home | alpes technologies
madwolf.com	madwolf technologies- home
alpestechnologies.com	home | alpes technologies
eyenetics.fr	home - see fast technologies
zeustechnologies.com	zeus technologies. home.
crucible-technologies.co.uk	crucible technologies - home
motorlebentechnologies.com	home - motorleben technologies
rifemachineuk.com	rife technologies - home
atipeek.com	atipeek, home tendance et technologies
dundeetechnologies.com	dundee sustainable technologies - home

tradingsat.com euronext.com investir.lesechos.fr bourse.fortuneo.fr votreargent.lexpress.fr boursedirect.fr journal-officiel.gouv.fr matttew.com fr.amoureux.com bonjourdefrance.com dragees-dor.com journaldunet.com cathedrale-chartres.org cabourg.net audiheritage.be 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.4.10 (Debian) contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

median technologies – the imaging phenomics company median technologies fr usa 中文 home about us back about us our core values technology capabilities quality strategic partners careers contact us patient care back patient care mediscan® radiology routine lung cancer screening & monitoring programs mediscan® support clinical trials back clinical trials services technology operational excellence imaging endpoints therapeutic areas modalities ibiopsy® back ibiopsy® the limits of genomics the phenomics revolution imaging phenomics ibiopsy® big data platform news & events back news & events webinars press releases conferences in the press blog resource library back resource library videos brochures white papers case studies scientific publications investors back investors message from the ceo board of directors & management team major shareholders stock market data financial agenda press releases & documentation investor contacts harnessing the power of imaging phenomics at median, we’re transforming the science of medical imaging. by harnessing the power of imaging phenomics we can improve current treatment, enhance diagnosis and accelerate development of next generation therapies, helping make a healthier world for millions. the fight against disease is a joint effort while our expertise and resources are unique, we don’t work alone. the fight against disease is a joint effort and the spirit of cooperation is found in everything we do. whether working in clinical trials or patient care and treatment, we share the same single-minded goal. to defeat the diseases that still touch so many lives. pushing the boundaries of imaging technology at median we’re determined to push the boundaries of what imaging technology can achieve, to help develop next generation treatments with the potential to save or improve the lives of millions. ceo’s message fredrik brag talks about how we’re looking to change the game. to transform the landscape in which we work and create a new world of possibilities for biopharma companies and healthcare professionals alike. read more the imaging phenomics company® median technologies is the imaging phenomics company®. learn about our mediscan® portfolio for patient care, our lesion management solution (lms) technology and ibiopsy®, our imaging biomarker phenotyping system. watch news 12 july 2018 median technologies receives the forbes 2018 futur40 award and special recognition prize for the “health-life sciences” company category median technologies, the imaging phenomics company®, announces that on july 11, it received the 2018 futur40 award and special recognition prize in the category “health-life sciences”. these prizes are awarded by forbes, pmefinance-europeentrepreneurs and their partners euronext, morningstar, rsm, f2ic and paris europlace to distinguish french champions of growth. read more 10 july 2018 half-year liquidity contract statement signed between median technologies and aurel bgc half-year liquidity contract statement signed between median technologies and aurel bgc at june 30, 2018. read more 31 may 2018 median technologies to attend the 2018 asco annual meeting, june 1-5, 2018, mccormick place, chicago, il, usa median technologies will share and showcase its offering for imaging solutions and services in clinical trials, featuring isee®, their next generation image analysis and management platform, and imagebank™, their latest solution for phase i cancer centers, at booth #6106. read more 24 may 2018 median technologies appoints dr. yan liu as medical director, europe press release – for immediate release – 5:45p. cest median technologies appoints dr. yan liu as medical director, europe dr. yan liu will… read more 26 april 2018 median technologies launches imagebank™ median technologies launches imagebank™ – new service offering enables efficient medical image collection and storage for phase i oncology clinical trials. read more 1/5 opinion 10 july 2018 demystifying how images are managed demystifying how images are managed between february 2017 and january 2018, ~41.4 million diagnostic imaging tests were performed in england[i]. that so many… read more 18 june 2018 asco 2018: headlines and highlights asco 2018: headlines and highlights all eyes were on the american society of clinical oncology (asco) annual conference last week in chicago watching… read more 15 may 2018 immunotherapy update: recent advances in car t-cell therapy immunotherapy update: recent advances in car t-cell therapy as a measure of its promise, chimeric antigen receptor (car) t-cell therapy – where patients’… read more 14 march 2018 industry trends: ai revolutionizes imaging analysis industry trends: ai revolutionizes imaging analysis the radiology industry is embracing artificial intelligence (ai) to enhance image analysis, and it’s having a profound impact… read more 9 january 2018 the value of standardized quality and performance metrics in clinical trials the value of standardized quality and performance metrics in clinical trials it’s not just tumor measurements that matter! quality and performance measurements are… read more 1/5 imaging for patient care identifying treatments that work imaging biomarkers provide a unique insight into treatment progress at every stage of a disease. in cancer for instance, comprehensive quantitative information plays an invaluable role in defining, tracking and measuring treatment outcomes. providing clear evidence of what works and what doesn’t. read more imaging for clinical trials advancing treatments of the future working with biopharmaceutical companies, and leading medical centers around the world, the team at median enable researchers to identify disease fingerprints from medical images. we’re helping paving the way for new personalized and innovative medicines, more accurate and predictable diagnoses and better treatments read more ibiopsy® powering the phenomics revolution we’re changing the game; transforming the landscape. we’re capturing the power of big data and unique biomarker imaging technology to create a new world of possibilities for biopharma and healthcare professionals alike. our ibiopsy® platform opens up the field of phenomics, driving the science of precision medicine. read more investors delivering value our technology and expertise is creating a new world of possibilities for biopharmaceutical and healthcare professionals around the world. by successfully helping improve the lives of millions, we are also delivering value for our investors and partners. read more quick links overview investor contact management team stock market data ticker: almdt isin: fr0011049824 get in touch europe united states china china 12/f platinum tower 233 tai cang road shanghai 200020 china tel +86 021 51757777 europe median technologies les deux arcs, bât b 1800, route des crêtes 06560 valbonne france tel +33 (0)4 93 333 777 united states legal address median technologies inc c/o pramex international 1251 avenue of the americas 3rd floor new york ny 10020 us offices median technologies inc 300 tradecenter suite 5610 woburn ma 01801 tel +1 781 305 3363 get in touch get in touch name company email address your message jobs at median quick links about us patient care clinical trials ibiopsy® news & events resources investors news & events resources investors -- get in touch info@mediantechnologies.com register for email alerts careers apply for vacancies at median technologies china 12/f platinum tower 233 tai cang road shanghai 200020 china europe median technologies les deux arcs b 1800 route des crêtes 06560 valbonne france united states median technologies inc 300 tradecenter, suite 5610 woburn, ma 01801 usa © copyright median technologies site map legal notice design by thinkerdoer download to download this content please complete the form below first name* last name* email address company name job title yes! please add me to your list to receive updates, educat

Analyse PopURL pour mediantechnologies.com

http://www.mediantechnologies.com/the-value-of-standardized-quality-and-performance-metrics-in-clinical-trials/
http://www.mediantechnologies.com/ibiopsy/#!ibiopsy-big-data-platform
http://www.mediantechnologies.com/site-map/
http://www.mediantechnologies.com/imaging-for-clinical-trials/#!imaging-endpoints
http://www.mediantechnologies.com/investors/press-releases-reports-presentations-shareholder-meetings/
http://www.mediantechnologies.com/press-release/median-technologies-receives-the-forbes-2018-futur40-award-and-special-recognition-prize-for-the-health-life-sciences-company-category/
http://www.mediantechnologies.com/imaging-for-clinical-trials/
http://www.mediantechnologies.com/videos/
http://www.mediantechnologies.com/blog/
http://www.mediantechnologies.com/webinars/
http://www.mediantechnologies.com/imaging-for-patient-care/
http://www.mediantechnologies.com/case-studies/
http://www.mediantechnologies.com/imaging-for-patient-care/#!lms-support
http://www.mediantechnologies.com/ibiopsy/
http://www.mediantechnologies.com/legal-notice/

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: MEDIANTECHNOLOGIES.COM
Registry Domain ID: 90741456_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2016-11-16T09:48:07Z
Creation Date: 2002-09-29T22:50:51Z
Registry Expiry Date: 2018-09-29T22:50:51Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: ok https://icann.org/epp#ok
Name Server: NS3.FR.CLARA.NET
Name Server: NS4.FR.CLARA.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-11T02:44:41Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Network Solutions, LLC.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =mediantechnologies.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME mediantechnologies.com

  CHANGED 2016-11-16

  CREATED 2002-09-29

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS3.FR.CLARA.NET 195.245.201.53

  NS4.FR.CLARA.NET 194.112.32.53

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.